PROF Profound Medical Corp.

NASDAQ
$6.63

Profound Medical Corp. (PROF) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.23 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.7% since its last earnings release on August 6, 2026.

Profound Medical Beat Consensus Estimates, Reaffirms
Thursday, August 6, 2026 · 4:12 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.23)
Rev est $7.15M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.98

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Profound Medical Corp.

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.

Sector

Healthcare

Industry

Medical Instruments/Supply